3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1163

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

-0.01 (-2.49%)

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

-0.01 (-2.38%)

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0177-OL:HK JIANGSU EXPRESS

+0.24 (+2.94%)

N/A
0240-OL:HK BUILD KING HOLD

-0.01 (-0.88%)

N/A
0243-OL:HK QPL INT'L

N/A

N/A
0182-OL:HK CHINA WINDPOWER

+0.01 (+1.56%)

N/A
0259-OL:HK YEEBO (INT'L H)

-0.03 (-0.83%)

N/A
0187-OL:HK JINGCHENG MAC

+0.03 (+1.25%)

N/A

ETFs Containing 3020-OL:HK

IHF iShares U.S. Healthcare P.. 9.16 % 0.43 %

+0.27 (+-0.14%)

USD 0.78B
TETF 6.19 % 0.64 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 5.32 % 0.00 %

N/A

CAD 0.05B
LCG Sterling Capital Focus Eq.. 4.33 % 0.00 %

-0.05 (-0.14%)

USD 0.07B
MID American Century Mid Cap .. 4.14 % 0.00 %

-0.02 (-0.14%)

USD 0.07B
IAI iShares U.S. Broker-Deale.. 3.81 % 0.42 %

+1.27 (+-0.14%)

USD 1.09B
STNC Stance Equity ESG Large C.. 3.75 % 0.00 %

-0.02 (-0.14%)

USD 0.11B
CBUF:XETRA iShares MSCI World Health.. 3.35 % 0.00 %

-0.04 (-0.14%)

USD 1.13B
HDIV 2.83 % 0.00 %

N/A

N/A
UBUS:F UBS (Irl) ETF Public Limi.. 2.41 % 0.00 %

-0.11 (-0.14%)

USD 0.32B
UBUW:F UBS (Irl) ETF Public Limi.. 2.41 % 0.00 %

-0.08 (-0.14%)

USD 0.02B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 2.41 % 0.00 %

-0.14 (-0.14%)

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 2.41 % 0.00 %

-0.15 (-0.14%)

USD 0.05B
TDOC:CA TD Global Healthcare Lead.. 2.41 % 0.00 %

-0.07 (-0.14%)

CAD 0.08B
NSGE:CA NBI Sustainable Global Eq.. 2.32 % 0.00 %

N/A

CAD 0.53B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 2.31 % 0.00 %

-6.50 (-0.14%)

USD 8.55M
UC96:LSE UBS (Irl) ETF plc - Facto.. 2.28 % 0.00 %

-20.00 (-0.14%)

USD 0.32B
FHH:CA First Trust AlphaDEX US H.. 2.18 % 0.77 %

+0.29 (+-0.14%)

CAD 0.01B
FHH-F:CA First Trust AlphaDEX U.S... 2.18 % 0.00 %

-0.08 (-0.14%)

CAD 0.01B
FXH First Trust Health Care A.. 2.08 % 0.63 %

+0.07 (+-0.14%)

USD 1.25B
FDWM Fidelity Covington Trust .. 1.84 % 0.00 %

-0.03 (-0.14%)

USD 4.39M
SPVM Invesco S&P 500 Value wit.. 1.75 % 0.39 %

+0.29 (+-0.14%)

USD 0.09B
RYH 1.72 % 0.40 %

N/A

N/A
IQSA:XETRA Invesco Quantitative Stra.. 1.50 % 0.00 %

-0.18 (-0.14%)

USD 0.07B
IQSE:XETRA Invesco Quantitative Stra.. 1.50 % 0.00 %

-0.25 (-0.14%)

USD 0.05B
HONR 1.20 % 0.65 %

N/A

N/A
RISN Inspire Tactical Balanced.. 1.12 % 0.00 %

-0.01 (-0.14%)

USD 0.09B
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.02 (+-0.14%)

USD 5.46M
DUSA 0.00 % 0.63 %

N/A

N/A
DRFU:CA Desjardins RI USA Multifa.. 0.00 % 0.57 %

N/A

CAD 5.97M
RYF 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

-0.35 (-0.14%)

USD 4.03B
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

+0.03 (+-0.14%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.78% 65% D 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.78% 65% D 70% C-
Trailing 12 Months  
Capital Gain 26.74% 89% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.74% 88% B+ 86% B+
Trailing 5 Years  
Capital Gain 88.19% 84% B 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 88.19% 84% B 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.84% 80% B- 79% B-
Dividend Return 14.84% 78% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.50% 73% C 73% C
Risk Adjusted Return 76.10% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike